Out of the 49.5 million-strong pharma workforce, only 11% of it is represented by females. Not only women but people of color, individuals from different ethnic backgrounds, and those from the LGBTQ+ community have often been underrepresented and neglected.
This lack of representation has a direct impact on the quality of products and the ecosystem at large. For instance, a lack of diversity has proven to result in pharmaceutical research that does not fully account for the varied responses to medication across different demographics, as most trial audiences have predominantly been the same for decades.
Recognizing this, forward-thinking companies in the pharma industry are increasingly turning to Employee Resource Groups (ERGs) to foster diversity, inclusion, and a sense of community among their workforce.